RxAnte and Aetna Discuss the Impact of Provider Engagement on Medication Adherence

Restricted Content

Please fill out the form below to access this content.

RxAnte President, Aaron McKethan and Aetna’s Vice President of Star Ratings, Mike Kavouras discuss pay for performance programs, medication adherence and the results of an innovative program that was launched in 2013 to engage providers in improving adherence for those patients predicted to be at high risk.

Aetna’s Mike Kavouras (VP of Star Ratings) and RxAnte’s Aaron McKethan (Senior Vice President) co-hosted a webinar during which they discussed pay for performance programs, medication adherence and the results of an innovative program that was launched in 2013 to engage providers in improving adherence for those patients predicted to be at high risk.

Highlights include:

Improving medication use represents one of the biggest opportunities to improve health outcomes and reduce unnecessary healthcare expenditures
Performance in medication adherence measures is a critical driver of overall performance in the CMS Star Rating program
Engaging providers is key to optimizing performance and improving medication adherence
By combining predictive analytics and other innovative program design elements, Aetna’s medication adherence P4P program effectively engaged physicians and yielded strong results

Related Resources

6.29.22

by Patricia Powers, PharmD

How Mosaic’s Comprehensive Pharmacy Support Enables Better Care at Home

As the Director of Clinical Services at Mosaic Pharmacy Service, Patricia Powers, Pharm.D. is responsible for overseeing the development and delivery of clinical services for all Mosaic members, RxAnte’s high-touch pharmacy service. This month we asked Dr. Powers to share her insights around at-home care coordination benefiting both the patient and the health system and how Mosaic’s comprehensive pharmacy support can help enable better care at home.

5.25.22

by Tori Erxleben Rush, PharmD

CMS Announcement for Medicare Advantage Part C and D plans

In early April, the Center for Medicaid and Medicare Services shared its Announcement for Medicare Advantage Part C and D plans, incorporating feedback solicited after an Advance Notice was issued in February 2022. Overall, not much has changed since the Advance Notice, however CMS addressed the comments issued by Medicare Advantage stakeholders like MA organizations and prescription drug plan sponsors.

4.4.22

The need for value-based pharmacy services

There is a strong push among physicians to transition to care models that incentivize fewer, more effective treatments. This same perspective should also be held in pharmacy. As we look to a post-pandemic healthcare system, improvements need to be made to remedy these concerns with focuses on barriers to optimal quality and cost--particularly for the medically complex and socially vulnerable.